Dermapharm Holding SE (XTER:DMP) Total Equity : €608 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Total Equity?

Dermapharm Holding SE's total equity for the quarter that ended in Dec. 2024 was €608 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Dermapharm Holding SE Total Equity Historical Data

The historical data trend for Dermapharm Holding SE's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Total Equity Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

324.58

499.83

532.49

545.05

608.30

Dermapharm Holding SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial															545.05	587.20	556.43	589.04	608.30

Dermapharm Holding SE Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Dermapharm Holding SE's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	2080.019	-	1471.724
	=	608

Dermapharm Holding SE's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	2080.019	-	1471.724
	=	608

Dermapharm Holding SE Total Equity Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (XTER:DMP) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

0A5J:UK DMPd:UK DMP:Germany DMP:Germany DMP:Germany DMP:Austria

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.de

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts, and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing, and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals, and cosmetics products. Parallel import brands business operates under the AxiCorp brand.

Executives

Wilhelm Beier	Supervisory Board
Dr. Hans-georg Feldmeier	Board of Directors
Christof Dreibholz	Board of Directors
Lothar Lanz	Supervisory Board
Anja Schorn	Board Member Themis Beteiligungs-AG
Hilde Neumeyer	Board of Directors

Dermapharm Holding SE Headlines

No Headlines